0.19p-0.00 (-1.13%)25 Nov 2024, 13:51
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Graft Polymer (Uk) PLC Fundamentals

Company NameGraft Polymer (Uk) PLCLast Updated2024-11-25
IndustrySpecialty Industrial MachinerySectorIndustrials
Shares in Issue2.296 bnMarket Cap£4.43 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.03EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.1234Debt Equity Ratio0
Asset Equity Ratio1.2924Cash Equity Ratio0.0163
Quick Ratio0.1467Current Ratio0.15
Price To Book Value2.7049ROCE0

Graft Polymer (Uk) PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Graft Polymer (Uk) PLC Company Financials

Assets202320222021
Tangible Assets£39,000.00£701,000.00£364,000.00
Intangible Assets£2.07 m£2.07 m£2.07 m
Investments000
Total Fixed Assets£2.12 m£2.78 m£2.44 m
Stocks£51,000.00£187,000.000
Debtors£71,000.00£43,000.00£53,000.00
Cash & Equivalents£155,000.00£1.64 m£39,000.00
Other Assets000
Total Assets£2.43 m£4.94 m£2.57 m
Liabilities202320222021
Creditors within 1 year£386,000.00£367,000.00£1.32 m
Creditors after 1 year£22,000.00£18,000.000
Other Liabilities000
Total Liabilities£408,000.00£385,000.00£1.32 m
Net assets£2.03 m£4.55 m£1.25 m
Equity202320222021
Called up share capital£41,000.00£41,000.00£7,000.00
Share Premium£9.50 m£9.50 m£3.44 m
Profit / Loss-£3.12 m-£2.71 m0
Other Equity£2.03 m£4.55 m£1.25 m
Preference & Minorities000
Total Capital Employed£2.03 m£4.55 m£1.25 m
Ratios202320222021
Debt Ratio£0.01£0.000
Debt-to-Equity£0.01£0.000
Assets / Equity1.29241.29241.2924
Cash / Equity0.01630.01630.0163
EPS-£0.02-£0.030
Cash Flow202320222021
Cash from operating activities-£1.24 m-£2.36 m0
Cashflow before financing-£1.24 m£1.77 m0
Increase in Cash-£1.47 m£1.06 m0
Income202320222021
Turnover£587,000.00£542,000.000
Cost of sales£329,000.00£242,000.000
Gross Profit£258,000.00£300,000.000
Operating Profit-£3.12 m-£2.70 m0
Pre-Tax profit-£3.12 m-£2.71 m0

Graft Polymer (Uk) PLC Company Background

SectorIndustrials
ActivitiesGraft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.
Latest Interim Date13 Sep 2024
Latest Fiscal Year End Date30 Apr 2024

Graft Polymer (Uk) PLC Directors

AppointedNamePosition
2024-09-26Mr. Dennis J. PurcellNon-Executive Director,Chairman
2024-09-26Mr. Roby ZomerNon-Executive Director,Chairman
2024-08-01Mr. Victor BolduevExecutive Director,Chief Technical Officer
2024-08-12Ms. Yifat SteuerExecutive Director,Chief Financial Officer
2024-07-15Mr. Pavel KobzevExecutive Director,Chief Marketing Officer
2024-06-28Mr. Alexander Samuel BrooksNon-Executive Director
2024-07-10Mr. Nicholas NelsonNon-Executive Director

Graft Polymer (Uk) PLC Contact Details

Company Name
Addressnull, null, null
Telephone
Websitehttps://www.graftpolymer.com

Graft Polymer (Uk) PLC Advisors